Listing 1 - 10 of 10 |
Sort by
|
Choose an application
This eBook is a collection of articles from a Frontiers Research Topic. Frontiers Research Topics are very popular trademarks of the Frontiers Journals Series: they are collections of at least ten articles, all centered on a particular subject. With their unique mix of varied contributions from Original Research to Review Articles, Frontiers Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author by contacting the Frontiers Editorial Office: frontiersin.org/about/contact
Cognition --- stress --- Motivation --- Behavior --- decision-making --- pre-frontal cortex
Choose an application
This eBook is a collection of articles from a Frontiers Research Topic. Frontiers Research Topics are very popular trademarks of the Frontiers Journals Series: they are collections of at least ten articles, all centered on a particular subject. With their unique mix of varied contributions from Original Research to Review Articles, Frontiers Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author by contacting the Frontiers Editorial Office: frontiersin.org/about/contact
Science: general issues --- Neurosciences --- Cognition --- stress --- Motivation --- Behavior --- decision-making --- pre-frontal cortex --- Cognition --- stress --- Motivation --- Behavior --- decision-making --- pre-frontal cortex
Choose an application
This eBook is a collection of articles from a Frontiers Research Topic. Frontiers Research Topics are very popular trademarks of the Frontiers Journals Series: they are collections of at least ten articles, all centered on a particular subject. With their unique mix of varied contributions from Original Research to Review Articles, Frontiers Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author by contacting the Frontiers Editorial Office: frontiersin.org/about/contact
Science: general issues --- Neurosciences --- Cognition --- stress --- Motivation --- Behavior --- decision-making --- pre-frontal cortex
Choose an application
Frontal lobes. --- Frontal Lobe. --- Cerebral cortex --- Anterior Central Gyrus --- Frontal Cortex --- Frontal Eye Fields --- Gyrus Precentralis --- Lobus Frontalis --- Precentral Gyrus --- Supplementary Eye Field --- Central Gyrus, Anterior --- Cortex, Frontal --- Cortices, Frontal --- Eye Field, Frontal --- Eye Field, Supplementary --- Eye Fields, Frontal --- Eye Fields, Supplementary --- Field, Frontal Eye --- Field, Supplementary Eye --- Fields, Frontal Eye --- Fields, Supplementary Eye --- Frontal Cortices --- Frontal Eye Field --- Frontal Lobes --- Frontali, Lobus --- Frontalis, Lobus --- Gyrus Precentrali --- Gyrus, Anterior Central --- Gyrus, Precentral --- Lobe, Frontal --- Lobes, Frontal --- Lobus Frontali --- Precentrali, Gyrus --- Precentralis, Gyrus --- Supplementary Eye Fields
Choose an application
The brain sciences are influencing our understanding of human behavior as never before, from neuropsychiatry and neuroeconomics to neurotheology and neuroaesthetics. Many now believe that the brain is what makes us human, and it seems that neuroscientists are poised to become the new experts in the management of human conduct. Neuro describes the key developments--theoretical, technological, economic, and biopolitical--that have enabled the neurosciences to gain such traction outside the laboratory. It explores the ways neurobiological conceptions of personhood are influencing everything from child rearing to criminal justice, and are transforming the ways we "know ourselves" as human beings. In this emerging neuro-ontology, we are not "determined" by our neurobiology: on the contrary, it appears that we can and should seek to improve ourselves by understanding and acting on our brains. Neuro examines the implications of this emerging trend, weighing the promises against the perils, and evaluating some widely held concerns about a neurobiological "colonization" of the social and human sciences. Despite identifying many exaggerated claims and premature promises, Neuro argues that the openness provided by the new styles of thought taking shape in neuroscience, with its contemporary conceptions of the neuromolecular, plastic, and social brain, could make possible a new and productive engagement between the social and brain sciences. Copyright note: Reproduction, including downloading of Joan Miro works is prohibited by copyright laws and international conventions without the express written permission of Artists Rights Society (ARS), New York. ?
Neuropsychology. --- Neurophysiology --- Psychophysiology --- Neuropsychology --- brein --- hersenen --- neurowetenschappen --- Brain --- Neurosciences --- cerveaux --- neurosciences --- methods --- physiopathology --- Neuropsychologie --- Cognitive psychology --- amygdala. --- animal experiments. --- animal models. --- artificiality. --- behavioral research. --- biological processes. --- brain activation. --- brain function. --- brain imaging data. --- brain imaging. --- brain science. --- brain size. --- brain structure. --- clinical medicine. --- cognition. --- criminal conduct. --- criminal justice system. --- emotion. --- environmental influences. --- evolution. --- functional brain imaging. --- gene expression. --- genomics. --- human antisocial behavior. --- human behavior. --- human brain. --- human cognition. --- human sciences. --- mental illness. --- mental life. --- mental processes. --- mental states. --- molecules. --- mouse brain. --- nerve development. --- nervous system. --- neural activity. --- neural mechanisms. --- neuroaesthetics. --- neurobiological evidence. --- neurobiological self. --- neurobiology. --- neuroeconomics. --- neuromolecular brain. --- neuron regeneration. --- neuronal circuits. --- neuropsychiatry. --- neuroscience. --- neurotheology. --- orbital frontal cortex. --- plastic brain. --- plasticity. --- psychiatric classification. --- psychiatric diagnosis. --- psychiatric disorders. --- psychiatric research. --- psychiatry. --- psychology. --- reductionist approach. --- risk assessment. --- risk management. --- risk reduction. --- self-management. --- self-understanding. --- selfhood. --- social brain hypothesis. --- social brain. --- social groups. --- social sciences. --- sociality. --- somatic individuality. --- synaptic plasticity. --- temporal cortex. --- volition.
Choose an application
During the last 60 years the relevance of cannabis (Cannabis sativa or Cannabis indica) ingredients, like the psychoactive Δ9-tetrahydrocannabinol (THC), cannabidiol, 120+ additional cannabinoids and 440+ non-cannabinoid compounds, for human health and disease has become apparent. Approximately 30 years after the elucidation of THC structure the molecular reasons for the biological activity of these plant extracts were made clearer by the discovery of endocannabinoids, that are endogenous lipids able to bind to the same receptors activated by THC. Besides endocannabinoids, that include several N-acylethanolamines and acylesters, a complex array of receptors, metabolic enzymes, transporters (transmembrane, intracellular and extracellular carriers) were also discovered, and altogether they form a so-called “endocannabinoid system” that has been shown to finely tune the manifold biological activities of these lipid signals. Both plant-derived cannabinoids and endocannabinoids were first discovered by the group led by Prof. Dr. Raphael Mechoulam, who has just celebrated his 90th birthday and clearly stood out as a giant of modern science. The many implications of his seminal work for chemistry, biochemistry, biology, pharmacology and medicine are described in this special issue by the scientists who reached during the last 20 years the highest recognition in the field of (endo)cannabinoid research, receiving the Mechoulam Award for their major contributions. I thank them for having accepted my invitation to be part of this honorary issue of Molecules, and Raphi for continuing to illuminate our field with his always inspiring investigations and new ideas.
Research & information: general --- Biology, life sciences --- Biochemistry --- cannabinoid --- MRI-1867 --- hybrid ligand --- CB1 receptor antagonist --- iNOS inhibitor --- rimonabant --- intracerebroventricular administration --- alcohol craving --- two-bottle paradigm --- drinking in the dark --- N-acyltransferase --- anandamide --- endocannabinoid --- phospholipase A2 --- cannabichromene --- cannabidiolic acid --- cannabidivarin --- cannabidivarinic acid --- phytocannabinoids --- tetrahydrocannabivarin --- 4′-fluoro-cannabidiol --- cannabinoid tetrad --- elevated plus maze --- catalepsy --- marble bury --- HUF-101 --- equilibrative nucleoside transporter --- CB1 --- biased signaling --- functional selectivity --- G-protein --- β-arrestin --- cannabigerol --- anti-inflammatory --- obesity --- cannabinoid receptor 2 (CB2R) --- microglia --- inflammaging --- memory --- lipofuscin --- aminoalkylindole --- allodynia --- antinociception --- cannabinoid receptor --- CP55940 --- JWH-018 --- K2 --- pravadoline --- spice --- WIN55212-2 --- type 1 cannabinoid receptor CB1 --- cholesterol --- hippocampus --- frontal cortex --- synaptosomes --- rescue model --- anti-CB1 antibody --- cannabinoids --- GPR55 receptors --- VCE-006.1 --- chromenopyrazole --- Parkinson’s disease --- 6-hydroxydopamine --- lipopolysaccharide --- amyotrophic lateral sclerosis --- mSOD1 mice --- TDP-43 transgenic mice --- PPARs --- gut microbiome --- intestine --- ghrelin --- LEAP2 --- n/a --- 4'-fluoro-cannabidiol --- Parkinson's disease
Choose an application
During the last 60 years the relevance of cannabis (Cannabis sativa or Cannabis indica) ingredients, like the psychoactive Δ9-tetrahydrocannabinol (THC), cannabidiol, 120+ additional cannabinoids and 440+ non-cannabinoid compounds, for human health and disease has become apparent. Approximately 30 years after the elucidation of THC structure the molecular reasons for the biological activity of these plant extracts were made clearer by the discovery of endocannabinoids, that are endogenous lipids able to bind to the same receptors activated by THC. Besides endocannabinoids, that include several N-acylethanolamines and acylesters, a complex array of receptors, metabolic enzymes, transporters (transmembrane, intracellular and extracellular carriers) were also discovered, and altogether they form a so-called “endocannabinoid system” that has been shown to finely tune the manifold biological activities of these lipid signals. Both plant-derived cannabinoids and endocannabinoids were first discovered by the group led by Prof. Dr. Raphael Mechoulam, who has just celebrated his 90th birthday and clearly stood out as a giant of modern science. The many implications of his seminal work for chemistry, biochemistry, biology, pharmacology and medicine are described in this special issue by the scientists who reached during the last 20 years the highest recognition in the field of (endo)cannabinoid research, receiving the Mechoulam Award for their major contributions. I thank them for having accepted my invitation to be part of this honorary issue of Molecules, and Raphi for continuing to illuminate our field with his always inspiring investigations and new ideas.
cannabinoid --- MRI-1867 --- hybrid ligand --- CB1 receptor antagonist --- iNOS inhibitor --- rimonabant --- intracerebroventricular administration --- alcohol craving --- two-bottle paradigm --- drinking in the dark --- N-acyltransferase --- anandamide --- endocannabinoid --- phospholipase A2 --- cannabichromene --- cannabidiolic acid --- cannabidivarin --- cannabidivarinic acid --- phytocannabinoids --- tetrahydrocannabivarin --- 4′-fluoro-cannabidiol --- cannabinoid tetrad --- elevated plus maze --- catalepsy --- marble bury --- HUF-101 --- equilibrative nucleoside transporter --- CB1 --- biased signaling --- functional selectivity --- G-protein --- β-arrestin --- cannabigerol --- anti-inflammatory --- obesity --- cannabinoid receptor 2 (CB2R) --- microglia --- inflammaging --- memory --- lipofuscin --- aminoalkylindole --- allodynia --- antinociception --- cannabinoid receptor --- CP55940 --- JWH-018 --- K2 --- pravadoline --- spice --- WIN55212-2 --- type 1 cannabinoid receptor CB1 --- cholesterol --- hippocampus --- frontal cortex --- synaptosomes --- rescue model --- anti-CB1 antibody --- cannabinoids --- GPR55 receptors --- VCE-006.1 --- chromenopyrazole --- Parkinson’s disease --- 6-hydroxydopamine --- lipopolysaccharide --- amyotrophic lateral sclerosis --- mSOD1 mice --- TDP-43 transgenic mice --- PPARs --- gut microbiome --- intestine --- ghrelin --- LEAP2 --- n/a --- 4'-fluoro-cannabidiol --- Parkinson's disease
Choose an application
During the last 60 years the relevance of cannabis (Cannabis sativa or Cannabis indica) ingredients, like the psychoactive Δ9-tetrahydrocannabinol (THC), cannabidiol, 120+ additional cannabinoids and 440+ non-cannabinoid compounds, for human health and disease has become apparent. Approximately 30 years after the elucidation of THC structure the molecular reasons for the biological activity of these plant extracts were made clearer by the discovery of endocannabinoids, that are endogenous lipids able to bind to the same receptors activated by THC. Besides endocannabinoids, that include several N-acylethanolamines and acylesters, a complex array of receptors, metabolic enzymes, transporters (transmembrane, intracellular and extracellular carriers) were also discovered, and altogether they form a so-called “endocannabinoid system” that has been shown to finely tune the manifold biological activities of these lipid signals. Both plant-derived cannabinoids and endocannabinoids were first discovered by the group led by Prof. Dr. Raphael Mechoulam, who has just celebrated his 90th birthday and clearly stood out as a giant of modern science. The many implications of his seminal work for chemistry, biochemistry, biology, pharmacology and medicine are described in this special issue by the scientists who reached during the last 20 years the highest recognition in the field of (endo)cannabinoid research, receiving the Mechoulam Award for their major contributions. I thank them for having accepted my invitation to be part of this honorary issue of Molecules, and Raphi for continuing to illuminate our field with his always inspiring investigations and new ideas.
Research & information: general --- Biology, life sciences --- Biochemistry --- cannabinoid --- MRI-1867 --- hybrid ligand --- CB1 receptor antagonist --- iNOS inhibitor --- rimonabant --- intracerebroventricular administration --- alcohol craving --- two-bottle paradigm --- drinking in the dark --- N-acyltransferase --- anandamide --- endocannabinoid --- phospholipase A2 --- cannabichromene --- cannabidiolic acid --- cannabidivarin --- cannabidivarinic acid --- phytocannabinoids --- tetrahydrocannabivarin --- 4'-fluoro-cannabidiol --- cannabinoid tetrad --- elevated plus maze --- catalepsy --- marble bury --- HUF-101 --- equilibrative nucleoside transporter --- CB1 --- biased signaling --- functional selectivity --- G-protein --- β-arrestin --- cannabigerol --- anti-inflammatory --- obesity --- cannabinoid receptor 2 (CB2R) --- microglia --- inflammaging --- memory --- lipofuscin --- aminoalkylindole --- allodynia --- antinociception --- cannabinoid receptor --- CP55940 --- JWH-018 --- K2 --- pravadoline --- spice --- WIN55212-2 --- type 1 cannabinoid receptor CB1 --- cholesterol --- hippocampus --- frontal cortex --- synaptosomes --- rescue model --- anti-CB1 antibody --- cannabinoids --- GPR55 receptors --- VCE-006.1 --- chromenopyrazole --- Parkinson's disease --- 6-hydroxydopamine --- lipopolysaccharide --- amyotrophic lateral sclerosis --- mSOD1 mice --- TDP-43 transgenic mice --- PPARs --- gut microbiome --- intestine --- ghrelin --- LEAP2 --- cannabinoid --- MRI-1867 --- hybrid ligand --- CB1 receptor antagonist --- iNOS inhibitor --- rimonabant --- intracerebroventricular administration --- alcohol craving --- two-bottle paradigm --- drinking in the dark --- N-acyltransferase --- anandamide --- endocannabinoid --- phospholipase A2 --- cannabichromene --- cannabidiolic acid --- cannabidivarin --- cannabidivarinic acid --- phytocannabinoids --- tetrahydrocannabivarin --- 4'-fluoro-cannabidiol --- cannabinoid tetrad --- elevated plus maze --- catalepsy --- marble bury --- HUF-101 --- equilibrative nucleoside transporter --- CB1 --- biased signaling --- functional selectivity --- G-protein --- β-arrestin --- cannabigerol --- anti-inflammatory --- obesity --- cannabinoid receptor 2 (CB2R) --- microglia --- inflammaging --- memory --- lipofuscin --- aminoalkylindole --- allodynia --- antinociception --- cannabinoid receptor --- CP55940 --- JWH-018 --- K2 --- pravadoline --- spice --- WIN55212-2 --- type 1 cannabinoid receptor CB1 --- cholesterol --- hippocampus --- frontal cortex --- synaptosomes --- rescue model --- anti-CB1 antibody --- cannabinoids --- GPR55 receptors --- VCE-006.1 --- chromenopyrazole --- Parkinson's disease --- 6-hydroxydopamine --- lipopolysaccharide --- amyotrophic lateral sclerosis --- mSOD1 mice --- TDP-43 transgenic mice --- PPARs --- gut microbiome --- intestine --- ghrelin --- LEAP2
Choose an application
Even though initially considered as a passive means for storing energy, lipids are now regarded as multifaceted molecules with crucial structural and functional activities. For instance, some of them play essential roles as key components of cell membranes whereas others act as signaling molecules in the regulation of cell homeostasis. In recent years, lipid research has attracted increasing interest because of the involvement of this class of compounds in human health. Indeed, a plethora of pathological conditions are characterized by alterations in lipid metabolism, such as cardiovascular diseases and brain disorders. This Special Issue is a collection of papers from different experts in lipid research, with the aim of providing new insights into the physiopathological involvement of lipids and their impact on human health. This collection also demonstrates the usefulness of interdisciplinary approaches in the development of novel methods to study and manipulate lipid metabolism, which may represent an attractive target for designing effective therapeutic strategies to counteract numerous pathologies.
Medicine --- neutral sphingomyelinase --- radiation --- sphingomyelin metabolism --- pathology --- cell signaling --- brain --- adipose tissue --- breast cancer --- epinephrine --- breast reconstruction --- epicardial fat thickness --- visceral fat thickness --- high-sensitivity c-reactive protein --- leptin --- gender --- female --- hippocampus --- frontal cortex --- adiponectin --- haptoglobin --- lipocalin --- BDNF --- synaptic proteins --- phosphatidylinositol 4,5-bisphosphate --- phospholipase C --- cholesterol --- high-cholesterol diet --- BET proteins --- cell proliferation --- epigenetics --- HMGCR --- JQ1 --- LDLr --- lipid metabolism --- SREBP --- TMEM97 --- atherosclerosis --- diabetes mellitus --- cardiovascular disease --- chronic inflammation --- hyperglycemia --- mutations --- lipid --- fatty acid --- glyceride --- steroid --- phospholipid --- oral drug absorption --- prodrug --- phospholipase A2 (PLA2) --- acid sphingomyelinase --- SOD --- liver --- eicosanoids --- ischemic stroke --- ischemia --- lipoproteins --- polyunsaturated fatty acids --- angiogenesis --- high-density lipoprotein --- endothelial cell --- metabolism --- metabolic reprogramming --- pulmonary fibrosis --- lipid mediators --- sphingolipids --- sphingosine-1-phosphate --- sphingosine kinase 1 --- prostaglandins --- lysophosphatidic acid --- autotaxin --- G-protein coupled receptors --- lysocardiolipin acyltransferase --- phospholipase D --- oxidized phospholipids --- DNA damage response --- double strand breaks --- ATM --- ionizing radiation --- metabolic stress --- oxidative stress --- p53 --- nuclear sphingolipids --- lipophagy --- lipolysis --- lipid droplets --- lipid storage diseases --- lipid metabolism diseases --- mTORC1 --- TFEB --- Cholesterol --- Fatty acids --- Lipid mediators --- Lipids --- Lipophagy --- Sphingolipids --- neutral sphingomyelinase --- radiation --- sphingomyelin metabolism --- pathology --- cell signaling --- brain --- adipose tissue --- breast cancer --- epinephrine --- breast reconstruction --- epicardial fat thickness --- visceral fat thickness --- high-sensitivity c-reactive protein --- leptin --- gender --- female --- hippocampus --- frontal cortex --- adiponectin --- haptoglobin --- lipocalin --- BDNF --- synaptic proteins --- phosphatidylinositol 4,5-bisphosphate --- phospholipase C --- cholesterol --- high-cholesterol diet --- BET proteins --- cell proliferation --- epigenetics --- HMGCR --- JQ1 --- LDLr --- lipid metabolism --- SREBP --- TMEM97 --- atherosclerosis --- diabetes mellitus --- cardiovascular disease --- chronic inflammation --- hyperglycemia --- mutations --- lipid --- fatty acid --- glyceride --- steroid --- phospholipid --- oral drug absorption --- prodrug --- phospholipase A2 (PLA2) --- acid sphingomyelinase --- SOD --- liver --- eicosanoids --- ischemic stroke --- ischemia --- lipoproteins --- polyunsaturated fatty acids --- angiogenesis --- high-density lipoprotein --- endothelial cell --- metabolism --- metabolic reprogramming --- pulmonary fibrosis --- lipid mediators --- sphingolipids --- sphingosine-1-phosphate --- sphingosine kinase 1 --- prostaglandins --- lysophosphatidic acid --- autotaxin --- G-protein coupled receptors --- lysocardiolipin acyltransferase --- phospholipase D --- oxidized phospholipids --- DNA damage response --- double strand breaks --- ATM --- ionizing radiation --- metabolic stress --- oxidative stress --- p53 --- nuclear sphingolipids --- lipophagy --- lipolysis --- lipid droplets --- lipid storage diseases --- lipid metabolism diseases --- mTORC1 --- TFEB --- Cholesterol --- Fatty acids --- Lipid mediators --- Lipids --- Lipophagy --- Sphingolipids
Choose an application
Even though initially considered as a passive means for storing energy, lipids are now regarded as multifaceted molecules with crucial structural and functional activities. For instance, some of them play essential roles as key components of cell membranes whereas others act as signaling molecules in the regulation of cell homeostasis. In recent years, lipid research has attracted increasing interest because of the involvement of this class of compounds in human health. Indeed, a plethora of pathological conditions are characterized by alterations in lipid metabolism, such as cardiovascular diseases and brain disorders. This Special Issue is a collection of papers from different experts in lipid research, with the aim of providing new insights into the physiopathological involvement of lipids and their impact on human health. This collection also demonstrates the usefulness of interdisciplinary approaches in the development of novel methods to study and manipulate lipid metabolism, which may represent an attractive target for designing effective therapeutic strategies to counteract numerous pathologies.
neutral sphingomyelinase --- radiation --- sphingomyelin metabolism --- pathology --- cell signaling --- brain --- adipose tissue --- breast cancer --- epinephrine --- breast reconstruction --- epicardial fat thickness --- visceral fat thickness --- high-sensitivity c-reactive protein --- leptin --- gender --- female --- hippocampus --- frontal cortex --- adiponectin --- haptoglobin --- lipocalin --- BDNF --- synaptic proteins --- phosphatidylinositol 4,5-bisphosphate --- phospholipase C --- cholesterol --- high-cholesterol diet --- BET proteins --- cell proliferation --- epigenetics --- HMGCR --- JQ1 --- LDLr --- lipid metabolism --- SREBP --- TMEM97 --- atherosclerosis --- diabetes mellitus --- cardiovascular disease --- chronic inflammation --- hyperglycemia --- mutations --- lipid --- fatty acid --- glyceride --- steroid --- phospholipid --- oral drug absorption --- prodrug --- phospholipase A2 (PLA2) --- acid sphingomyelinase --- SOD --- liver --- eicosanoids --- ischemic stroke --- ischemia --- lipoproteins --- polyunsaturated fatty acids --- angiogenesis --- high-density lipoprotein --- endothelial cell --- metabolism --- metabolic reprogramming --- pulmonary fibrosis --- lipid mediators --- sphingolipids --- sphingosine-1-phosphate --- sphingosine kinase 1 --- prostaglandins --- lysophosphatidic acid --- autotaxin --- G-protein coupled receptors --- lysocardiolipin acyltransferase --- phospholipase D --- oxidized phospholipids --- DNA damage response --- double strand breaks --- ATM --- ionizing radiation --- metabolic stress --- oxidative stress --- p53 --- nuclear sphingolipids --- lipophagy --- lipolysis --- lipid droplets --- lipid storage diseases --- lipid metabolism diseases --- mTORC1 --- TFEB --- Cholesterol --- Fatty acids --- Lipid mediators --- Lipids --- Lipophagy --- Sphingolipids
Listing 1 - 10 of 10 |
Sort by
|